Pharmaceuticals stocks
1,480 listed pharmaceuticals companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Resources Pharmaceutical Group LimitedSEHK: 3320 | $3.85B | HK$4.81 | -0.72% |
| Emcure Pharmaceuticals LimitedNSEI: EMCURE | $3.83B | Rs1,932.30 | -2.33% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $3.80B | ₩415,500.00 | +4.27% |
| Santen Pharmaceutical Co., Ltd.TSE: 4536 | $3.80B | ¥1,879.50 | -2.03% |
| Zhejiang Huahai Pharmaceutical Co., Ltd.SHSE: 600521 | $3.68B | CN¥16.62 | -5.19% |
| China Medical System Holdings LimitedSEHK: 867 | $3.63B | HK$11.69 | +2.45% |
| Organon & Co.NYSE: OGN | $3.61B | $13.75 | -0.04% |
| Laboratorios Farmaceuticos Rovi, S.A.BME: ROVI | $3.61B | €60.75 | +0.41% |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSHSE: 600329 | $3.57B | CN¥36.08 | +1.01% |
| Structure Therapeutics Inc.NasdaqGM: GPCR | $3.56B | $48.54 | -2.76% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $3.47B | CN¥20.72 | -8.12% |
| Hubei Jumpcan Pharmaceutical Co., Ltd.SHSE: 600566 | $3.42B | CN¥24.94 | +2.21% |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd.SZSE: 300255 | $3.35B | CN¥24.53 | -10.01% |
| Tasly Pharmaceutical Group Co., LtdSHSE: 600535 | $3.33B | CN¥14.97 | -2.35% |
| Jiangsu Nhwa Pharmaceutical Co., LTDSZSE: 002262 | $3.32B | CN¥21.95 | -0.05% |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.SZSE: 002317 | $3.31B | CN¥26.17 | -4.66% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $3.30B | $67.34 | -1.87% |
| Virbac SAENXTPA: VIRP | $3.22B | €330.50 | +0.46% |
| Wockhardt LimitedNSEI: WOCKPHARMA | $3.20B | Rs1,886.30 | -2.40% |
| Betta Pharmaceuticals Co., Ltd.SZSE: 300558 | $3.20B | CN¥51.18 | -25.49% |
| Tarsus Pharmaceuticals, Inc.NasdaqGS: TARS | $3.19B | $70.21 | -3.43% |
| Jilin Aodong Pharmaceutical Group Co., Ltd.SZSE: 000623 | $3.13B | CN¥17.97 | -0.88% |
| Neuland Laboratories LimitedBSE: 524558 | $3.12B | Rs23,294.80 | -0.07% |
| Alumis Inc.NasdaqGS: ALMS | $3.10B | $23.09 | -3.63% |
| Livzon Pharmaceutical Group Inc.SZSE: 000513 | $3.08B | CN¥26.34 | +1.42% |
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $3.06B | CN¥8.17 | -8.31% |
| Hybio Pharmaceutical Co., Ltd.SZSE: 300199 | $3.04B | CN¥23.10 | -10.67% |
| Hypera S.A.BOVESPA: HYPE3 | $2.98B | R$21.80 | +1.77% |
| Piramal Pharma LimitedNSEI: PPLPHARMA | $2.96B | Rs213.67 | +3.40% |
| Chengdu Kanghong Pharmaceutical Group Co., LtdSZSE: 002773 | $2.89B | CN¥21.11 | -6.80% |
| Sam Chun Dang Pharm. Co., LtdKOSDAQ: A000250 | $2.85B | ₩168,700.00 | -10.74% |
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $2.83B | HK$38.50 | +6.29% |
| Rubicon Research LimitedNSEI: RUBICON | $2.80B | Rs1,619.10 | +1.43% |
| Kangmei Pharmaceutical Co., Ltd.SHSE: 600518 | $2.80B | CN¥1.36 | -3.55% |
| AtaiBeckley Inc.NasdaqGM: ATAI | $2.76B | $7.44 | 0.00% |
| Acutaas Chemicals LimitedNSEI: ACUTAAS | $2.71B | Rs3,169.00 | -2.06% |
| Regencell Bioscience Holdings LimitedNasdaqCM: RGC | $2.70B | $5.50 | +0.92% |
| Jamjoom Pharmaceuticals Factory CompanySASE: 4015 | $2.65B | SR142.00 | +1.43% |
| Curaleaf Holdings, Inc.TSX: CURA | $2.64B | CA$13.49 | -1.75% |
| Almirall, S.A.BME: ALM | $2.64B | €10.44 | +0.58% |
| Supernus Pharmaceuticals, Inc.NasdaqGM: SUPN | $2.64B | $45.14 | -0.49% |
| Haw Par Corporation LimitedSGX: H02 | $2.63B | S$15.06 | -2.84% |
| Nektar TherapeuticsNasdaqCM: NKTR | $2.56B | $74.50 | -0.61% |
| Trevi Therapeutics, Inc.NasdaqGM: TRVI | $2.56B | $18.00 | +0.28% |
| Pharvaris N.V.NasdaqGS: PHVS | $2.55B | $36.50 | +0.63% |
| Bausch Health Companies Inc.NYSE: BHC | $2.52B | $6.77 | +0.59% |
| Nuvation Bio Inc.NYSE: NUVB | $2.49B | $6.94 | -2.25% |
| Rapport Therapeutics, Inc.NasdaqGM: RAPP | $2.46B | $50.22 | -1.86% |
| Joincare Pharmaceutical Group Industry Co.,Ltd.SHSE: 600380 | $2.45B | CN¥9.24 | -1.18% |
| ApicHope Pharmaceutical Group Co., Ltd.SZSE: 300723 | $2.45B | CN¥36.75 | -5.09% |
| Prestige Consumer Healthcare Inc.NYSE: PBH | $2.44B | $51.45 | -1.10% |
| Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858 | $2.43B | CN¥15.52 | -2.45% |
| Dermapharm Holding SEXTRA: DMP | $2.43B | €40.80 | -2.86% |
| China Resources Double-Crane Pharmaceutical Co.,Ltd.SHSE: 600062 | $2.41B | CN¥15.67 | -2.06% |
| Ocular Therapeutix, Inc.NasdaqGM: OCUL | $2.39B | $10.78 | -0.92% |
| BrightGene Bio-Medical Technology Co., Ltd.SHSE: 688166 | $2.37B | CN¥36.67 | -9.10% |
| Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867 | $2.36B | CN¥8.11 | -5.37% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.36B | HK$5.28 | +0.96% |
| Pfizer LimitedNSEI: PFIZER | $2.28B | Rs4,758.00 | -2.53% |
| Tonghua Golden-Horse Pharmaceutical Industry Co,LtdSZSE: 000766 | $2.28B | CN¥15.85 | -4.35% |
| Harmony Biosciences Holdings, Inc.NasdaqGM: HRMY | $2.27B | $39.53 | +1.49% |
| Aether Industries LimitedNSEI: AETHER | $2.26B | Rs1,626.60 | +0.09% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.25B | CN¥13.08 | -7.76% |
| The United Laboratories International Holdings LimitedSEHK: 3933 | $2.22B | HK$8.84 | -1.23% |
| Granules India LimitedBSE: 532482 | $2.22B | Rs858.45 | +0.04% |
| Fujian Cosunter Pharmaceutical Co., Ltd.SZSE: 300436 | $2.21B | CN¥93.12 | -6.37% |
| Trulieve Cannabis Corp.NYSE: TRLV | $2.18B | $11.32 | +1.62% |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.17B | CN¥23.15 | +2.80% |
| Zhejiang Jiuzhou Pharmaceutical Co., LtdSHSE: 603456 | $2.16B | CN¥16.60 | -5.25% |
| HUTCHMED (China) LimitedAIM: HCM | $2.12B | £1.79 | +0.56% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd.SZSE: 300573 | $2.10B | CN¥39.58 | +2.75% |
| PT Kalbe Farma Tbk.IDX: KLBF | $2.08B | Rp810.00 | +1.25% |
| Hanall Biopharma Co., Ltd.KOSE: A009420 | $2.07B | ₩56,500.00 | -5.36% |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.SZSE: 002399 | $2.06B | CN¥10.47 | -1.32% |
| Fujian Haixi Pharmaceuticals Co., Ltd.SEHK: 2637 | $2.05B | HK$204.80 | +3.28% |
| Neuren Pharmaceuticals LimitedASX: NEU | $2.04B | AU$22.46 | -4.22% |
| Caplin Point Laboratories LimitedBSE: 524742 | $2.03B | Rs2,558.10 | +3.12% |
| GH Research PLCNasdaqGM: GHRS | $2.02B | $28.45 | -3.53% |
| Perrigo Company plcNYSE: PRGO | $2.01B | $14.45 | -0.21% |
| Vigonvita Life Sciences Co., Ltd.SEHK: 2630 | $1.96B | HK$91.90 | -20.50% |
| Kardigan, Inc.NasdaqGM: KARD | $1.96B | $20.92 | +1.36% |
| AstraZeneca Pharma India LimitedBSE: 506820 | $1.94B | Rs7,410.50 | -4.43% |
| Septerna, Inc.NasdaqGM: SEPN | $1.93B | $40.60 | -1.69% |
| Eris Lifesciences LimitedNSEI: ERIS | $1.92B | Rs1,328.20 | -2.23% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.SZSE: 300357 | $1.92B | CN¥24.65 | -4.72% |
| Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.SHSE: 603707 | $1.91B | CN¥7.96 | -1.49% |
| Zhejiang Medicine Co., Ltd.SHSE: 600216 | $1.87B | CN¥13.23 | -0.75% |
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.85B | Rs463.00 | +5.07% |
| Shenzhen Chipscreen Biosciences Co., Ltd.SHSE: 688321 | $1.84B | CN¥27.95 | -9.40% |
| Caregen Co., Ltd.KOSDAQ: A214370 | $1.83B | ₩51,900.00 | -16.16% |
| Bora Pharmaceuticals Co., Ltd.TWSE: 6472 | $1.82B | NT$455.00 | +11.25% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.80B | $62.75 | -0.48% |
| PharmaBlock Sciences (Nanjing), Inc.SZSE: 300725 | $1.78B | CN¥51.46 | -6.04% |
| Beijing Aosaikang Pharmaceutical Co., Ltd.SZSE: 002755 | $1.78B | CN¥12.91 | -6.04% |
| Guobang Pharma Ltd.SHSE: 605507 | $1.78B | CN¥15.53 | -4.14% |
| Tsumura & Co.TSE: 4540 | $1.77B | ¥3,767.00 | +0.40% |
| Porton Pharma Solutions Ltd.SZSE: 300363 | $1.77B | CN¥21.89 | +0.09% |
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.75B | CN¥6.69 | -3.74% |
| Alivus Life Sciences LimitedNSEI: ALIVUS | $1.73B | Rs1,350.90 | -2.58% |
| Avalyn Pharma Inc.NasdaqGS: AVLN | $1.69B | $38.20 | +1.35% |